White blood cells, smoking and exercise training

Paper Details

Research Paper 01/02/2014
Views (178) Download (4)
current_issue_feature_image
publication_file

White blood cells, smoking and exercise training

Kaboli Mohamadzaman, Ferizadeh Abbas, Safdari Yazdan, Balali Jafar
J. Bio. Env. Sci.4( 2), 171-176, February 2014.
Certificate: JBES 2014 [Generate Certificate]

Abstract

Smoking role in lung and cardiovascular diseases has been known for years. In this study, we aimed to the effect exercise training for long term on white blood cell and other blood cells in smoker men. For this purpose, thirty adult smoker men aged 41.8 +/- 4.8 years, height 174.9 +/- 6.5 cm and weight 95.4 +/- 4.5 Kg was enrolled to participate in this study. Then they divided into exercise or control group. The subject in Exercise group were completed a aerobic exercise program lasted 3 months (3 sessions weekly) but control group banned of any exercise in this period. Venous blood samples were obtained before and after the aerobic training after overnight fast in order to measuring white blood cells count and other blood cells. Data analyzed by T test in the SPSS software version 15.0. The data of Student’s t-tests for paired samples showed a significant decrease in white blood cells count in exercise group but not in other blood cells. Based on our results, it is conclude that exercise training can be affect blood cells profile in smokers in

VIEWS 2

Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. 2007. Systemic Effects of Smoking. CcChest 11, 1557-1566.

Atlanta GA. 2000. Tobacco control: country profiles. American Cancer Society. 38-44.

Walters MJ, Paul-Clark MJ, McMaster SK. 2005. Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Molecular Pharmacology 68, 1343–1353.

Barbieri SS, Weksler BB. 2007. Tobacco smoke cooperates with interleukin-1ß to alter ß -catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo. Federation of American Societies for Experimental Biology 21, 1831–1843.

Weijenberg MP, Feskens EJ,Kromhout D.1996. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arteriosclerosis, Thrombosis, and Vascular Biology 16, 499–503.

DeFronzo RA, Ferrannini E. 1991. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194.

Naoya W, Mitsuo F, Ataru T, Takahide O, Yoshio N, Fusanori N, Sae A. 2011. Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance. Tobacco Induced Diseases 9(12), 2-6.

Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K. 2002. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 45, 42–48.

McCarty MF. 1999. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Medical Hypotheses 52, 465–477.

Noriyuki N, Kenji S, Kozo T. 2003. Association between lifestyle and white blood cell count: a study of Japanese male office workers. Occupational Medicine 53(2), 135-137.

Merghani TH, Saeed A, Alawad A. 2012. Changes in plasma IL4, TNFá and CRP in response to regular passive smoking at home among healthy school children in Khartoum, Sudan. African Health Sciences 12(1), 41-47.

Watanabe N, Fukushima M, Taniguchi A, Okumura T, Nomura Y, Nishimura F, Aoyama S. 2011. Smoking, white blood cell counts, and TNF system activity in Japanese male subjects with normal glucose tolerance. Tobacco Induced Diseases 9(1), 12.

Wasserman LR. 1973. Cigarette smoking and secondary polycythemia. Journal of the American Medical Association 224, 1654-1657.

Kapoor D, Jones TH. 2005. Smoking and hormones in health and endocrine disorders. European Journal of Endocrinology 152(4), 491-499.

Gidding SS, Xie X, Liu K, Manolio T, Flack J, Perkins L, Gardin J. 1992. Smoking has race/gender specific effects on resting cardiac function: the CARDIA study. Circulation 82, 877.

Berton G, Cordiano R, Palmieri R, Pianca S, Pagliara V, Palatini P. 2003.C-reactive protein in acute myocardial infarction: association with heart failure. American Heart Journal 145, 1094-1101.

Willems JM, Trompet S, Blauw GJ, Westendorp RG, Craen AJ. 2010. White Blood Cell Count and C – reactive protein are independent predictors of mortality in the oldest old. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 65, 764-768.

John DMB, Phil D. 2004. CRP and other circulatory markers of inflammation in prediction of coronary heart disease. New England Journal of Medicine 350, 1387-1451.

Schwartz J, Weiss ST. 1994. Cigarette smoking and peripheral blood leucocyte differentials. Annals of Epidemiology 4, 236-242.